CZEREPAK ELIZABETH 4
4 · Sorrento Therapeutics, Inc. · Filed May 20, 2022
Insider Transaction Report
Form 4
CZEREPAK ELIZABETH
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-18+350,000→ 350,000 totalExercise: $1.51Exp: 2032-05-18→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]1/4th of the original number of shares subject to the option shall vest on May 18, 2023, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.